Aplus Biotechnology Corporation Limited
6918.TWO
Taipei Exchange74.10
TWD
-0.10
- -
Aplus Biotechnology Corporation Limited
6918.TWO
(Taipei Exchange)
Recent
price
74.10
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- A Plus Biotechnology Co Ltd (6918.TWO) develops, manufactures and sells orthopedic trauma medical equipment under the A Plus brand; core products include orthopedic trauma implants such as bone plates, bone nails, intramedullary nails, cables and external fixators for various body parts; precision surgical instruments encompassing 3D-printed patient-specific guides, knee arthritis correction systems including high tibial osteotomy and distal femoral osteotomy systems, hallux valgus correction systems with Spear Plate, trochanter hip screws and additive manufacturing surgical guide plates; proxy biochemical and surgical products featuring joint injections like platelet-rich plasma (PRP), artificial bone, hemostatic powder and items from international brands; spinal fixation systems and intervertebral fusion devices. The company, founded in 2009 and headquartered at 3F, No 21 Qiaohe Rd, Zhonghe Dist, New Taipei City, Taiwan, designs implants tailored to Asian bone curvature for improved fit and reduced complications; it serves over 200 Taiwanese medical institutions monthly and exports to mainland China, other Asian countries, the United States and Africa, targeting orthopedic surgeons and hospitals amid rising demand from aging populations. In June 2025, A Plus lists on the Taiwan Stock Exchange, marking its public market debut; it recently expands precision medicine via international symposia in Malaysia on patient-specific implants, participates in 2025 events including the Taiwan Orthopaedic Trauma Association Annual Meeting, Taiwan Thoracic & Cardiovascular Surgery Congress, Asia Foot & Ankle Conference in Singapore and Fall Orthopedic Conference showcasing 3D PSI solutions, trauma fixation, rib systems, cryotherapy and portable ultrasound sponsorships; ongoing efforts deepen clinical collaborations through A Club (Taiwan Medical Device Innovation Association) and promote comprehensive foot & ankle solutions alongside Asian market penetration.